chapter
necrot
enterocol
stephen
kim
craig
albanes
necrot
enterocol
nec
lead
caus
morbid
mortal
neonat
intens
care
unit
nicu
around
world
advanc
perinat
neonat
care
contribut
grow
popul
prematur
infant
risk
nec
common
newborn
surgic
emerg
mortal
rate
far
exce
gastrointestin
gi
condit
requir
surgic
intervent
despit
extens
research
precis
caus
pathogenesi
remain
elus
paltauf
describ
five
patient
die
overwhelm
periton
caus
suggest
nec
three
despit
report
mani
credit
generisch
publish
first
report
nec
care
review
descript
find
almost
certainli
case
meconium
periton
rather
nec
theland
report
case
perfor
stomach
duodenum
small
larg
intestin
mani
patient
intestin
perfor
probabl
nec
first
report
success
treat
infant
local
ileal
perfor
result
nec
attribut
agerti
et
al
schmid
quaiser
first
use
term
necrot
enterocol
rossier
colleagu
describ
infant
die
ulcerativenecrot
enterocol
prematur
berdon
et
al
report
clinic
radiograph
find
patient
nec
year
later
mizrahi
et
al
report
case
nec
prematur
infant
incid
nec
new
york
babi
hospit
nurseri
diseas
caus
nurseri
death
santulli
et
al
hypothes
develop
diseas
three
essenti
compon
injuri
intestin
mucosa
presenc
bacteria
avail
metabol
substrat
treatment
nec
earli
surgeri
recogn
earli
diagnosi
patient
could
manag
without
surgeri
bell
et
al
publish
severitybas
classif
scheme
help
select
therapi
allow
comparison
outcom
intern
classif
diseas
establish
code
death
nec
therebi
allow
precis
epidemiolog
outcom
analys
true
incid
nec
unknown
vari
significantli
within
unit
state
worldwid
nec
account
nicu
admiss
unit
state
case
per
live
birth
infant
born
low
birth
weight
vlbw
g
diseas
occur
approxim
rang
depend
center
inquiri
worldwid
incid
nec
vlbw
infant
vari
japan
austria
greec
argentina
hong
kong
sever
confound
factor
may
account
variabl
includ
number
surviv
lowbirthweight
infant
sourc
patient
referr
inor
outborn
diagnost
criteria
use
rel
larg
multicent
survey
vlbw
infant
note
incid
definit
nec
suspect
nec
although
consider
intercent
variabl
anoth
studi
incid
definit
nec
versu
suspect
nec
respect
report
pokorni
et
al
inborn
neonat
includ
lowbirthweight
infant
incid
nec
per
live
birth
mani
seri
may
underestim
frequenc
nec
incid
often
defin
total
number
case
nec
divid
total
number
patient
admit
nicu
thu
figur
may
includ
mani
prematur
infant
die
within
first
day
life
cardiorespiratori
diseas
live
long
enough
nec
develop
one
studi
exclud
earli
neonat
death
includ
infant
fed
report
incid
recent
report
demonstr
strong
associ
nec
prematur
preterm
babi
low
gestat
age
birth
weight
particular
risk
estim
nec
case
occur
fullterm
infant
advent
earli
surfact
therapi
improv
method
mechan
ventil
result
signific
improv
surviv
lowand
extrem
lowbirthweight
infant
result
increas
popul
tini
infant
risk
develop
nec
futur
nec
may
surpass
respiratori
distress
syndrom
princip
caus
death
prematur
infant
age
matur
nec
predominantli
diseas
prematur
lowbirthweight
infant
rather
small
gestat
age
kliegman
fanaroff
report
mean
gestat
age
patient
nec
week
averag
birth
weight
g
patient
fullterm
small
gestat
age
infant
extrem
low
birth
weight
g
week
gestat
age
less
greatest
risk
larg
multicent
prospect
studi
involv
infant
weigh
g
lemon
et
al
demonstr
invers
relationship
incid
nec
birth
weight
incid
nec
highest
infant
weigh
g
declin
increas
weight
g
g
g
tesdal
et
al
report
invers
relationship
age
onset
nec
gestat
age
infant
nec
develop
first
week
life
matur
averag
gestat
age
week
nec
develop
week
age
averag
gestat
age
week
complic
common
mortal
rate
higher
patient
earlyonset
diseas
ostli
et
al
demonstr
similar
invers
relationship
gestat
age
onset
nec
fullterm
week
infant
significantli
earlier
onset
nec
day
preterm
week
infant
day
similarli
martineztallo
et
al
also
demonstr
earlier
onset
nec
day
infant
birth
weight
greater
g
wilson
et
al
calcul
birth
weightspecif
weekli
attack
rate
patient
nec
risk
period
nec
decreas
birth
weight
increas
found
consist
pattern
sharpli
declin
risk
attain
age
equival
week
gestat
suggest
function
matur
gi
tract
may
play
princip
role
determin
risk
nec
preterm
gi
tract
decreas
gastric
acid
product
lower
level
protect
mucu
increas
mucos
permeabl
absenc
normal
coordin
peristalt
activ
around
week
gestat
feed
nec
develop
approxim
infant
fed
wherea
develop
less
feed
initi
brown
sweet
propos
aggress
feed
protocol
contribut
pathogenesi
nec
found
chang
slowli
progress
feed
regimen
juli
case
nec
occur
lowbirthweight
infant
juli
june
cautiou
approach
feed
practic
case
develop
lowbirthweight
infant
total
patient
admit
nicu
longitudin
cohort
studi
review
incid
nec
period
implement
standard
feed
schedul
infant
weigh
g
less
week
gestat
kamitsuka
et
al
report
reduct
risk
nec
studi
also
suggest
associ
increas
incid
nec
advanc
formula
feed
rate
greater
kcalkgday
despit
report
howev
random
trial
fail
demonstr
differ
incid
nec
relat
fast
versu
slow
earli
versu
delay
continu
versu
intermitt
bolu
feed
random
trial
involv
vlbw
infant
slow
increment
schedul
full
feed
fast
increment
schedul
full
feed
feed
advanc
compar
rayyi
et
al
demonstr
signific
differ
incid
nec
versu
perfor
versu
mortal
versu
group
review
random
trial
compar
continu
versu
intermitt
bolu
tube
feed
prematur
infant
weigh
less
g
premji
chessel
could
find
signific
differ
incid
nec
two
group
recent
random
trial
investig
incid
nec
vlbw
infant
assign
receiv
either
minimalvolum
feed
mlkgday
day
advanc
fullvolum
feed
standard
feed
advanc
protocol
start
mlkg
increas
mlkgday
fullvolum
feed
berseth
et
al
report
significantli
lower
incid
nec
minimalvolum
group
standard
group
versu
differ
risk
nec
great
studi
close
earli
prolong
use
trophic
feed
volum
thought
trigger
matur
gi
function
studi
reinforc
previou
studi
gut
stimul
protocol
benefici
vlbw
infant
initi
minimalvolum
feed
protocol
day
follow
modest
advanc
feed
may
greatli
reduc
incid
nec
osmolar
composit
enter
feed
also
associ
increas
incid
nec
formula
high
osmolar
shown
increas
incid
nec
infant
caus
intestin
mucos
injuri
anim
model
de
lemo
et
al
demonstr
intestin
lesion
resembl
nec
newborn
goat
fed
hyperosmolar
formula
book
et
al
prospect
studi
preterm
infant
fed
either
element
mosmkg
bodi
weight
milk
mosmkg
formula
found
nec
develop
infant
fed
element
diet
infant
fed
milk
formula
grantmyr
associ
describ
one
patient
fatal
nec
develop
osmol
mosmkg
enema
administ
treatment
meconium
ileu
mani
oral
medic
vitamin
prepar
use
hyperosmolar
vehicl
could
potenti
lead
mucos
injuri
bowel
willi
et
al
report
significantli
higher
incid
nec
infant
fed
undilut
calcium
lactat
osmol
mosmkg
infant
fed
calcium
fed
calcium
lactat
dilut
water
formula
white
harkavi
report
mani
oral
medic
commonli
use
intens
care
nurseri
high
osmol
even
mix
formula
usual
vehicl
rather
medic
respons
high
osmol
finer
et
al
report
incid
nec
preterm
infant
receiv
oral
hyperosmolar
vitamin
e
prepar
compar
incid
infant
given
parenter
prepar
vitamin
e
propos
mechan
injuri
introduct
hyperosmolar
solut
gi
tract
though
prove
clinic
reduct
intestin
mucos
blood
flow
secondari
rapid
fluid
shift
intravascular
space
bowel
lumen
relev
mechan
intestin
injuri
develop
nec
clinic
set
unknown
xanthin
deriv
eg
theophyllin
aminophyllin
known
slow
intestin
motil
produc
oxygen
free
radic
metabol
uric
acid
report
associ
nec
william
robinson
et
al
describ
three
patient
nec
develop
receiv
oral
intraven
xanthin
apnea
prematur
anim
experi
cronin
et
al
demonstr
alter
gi
blood
flow
oxygen
deliveri
aminophyllin
administr
newborn
lamb
may
result
deplet
gi
oxygen
reserv
mucos
injuri
despit
earlier
report
subsequ
result
larg
patient
studi
fail
confirm
associ
administr
larg
dose
vitamin
e
prematur
infant
link
increas
nec
vitamin
e
given
reduc
incid
advers
sequela
retinopathi
prematur
infant
shown
interfer
intracellular
kill
bacteria
leukocyt
increas
incid
nec
howev
note
oral
administr
hyperosmolar
prepar
intramuscular
administr
indomethacin
block
prostaglandin
synthetas
caus
vasoconstrict
effect
exploit
close
patent
ductu
arteriosu
pda
prematur
infant
congest
heart
failur
gi
perfor
nec
note
lowbirthweight
infant
treat
highdos
indomethacin
postul
indomethacin
increas
mesenter
vascular
resist
reduc
mesenter
blood
flow
norton
et
al
demonstr
use
indomethacin
tocolyt
agent
associ
increas
incid
nec
babi
deliv
week
gestat
age
mean
age
deliveri
week
howev
indomethacin
increas
incid
nec
babi
born
week
gestat
retrospect
studi
involv
prematur
infant
symptomat
pda
treat
intraven
indomethacin
grosfeld
et
al
found
incid
nec
contrast
two
random
control
trial
involv
lowbirthweight
prematur
infant
receiv
earli
lowdos
indomethacin
versu
placebo
closur
pda
demonstr
differ
subsequ
incid
nec
indomethacin
may
enough
caus
nec
howev
set
hypoxia
heart
failur
sepsi
advers
gi
effect
contribut
develop
nec
vlbw
infant
cocain
potent
vasoconstrict
properti
dramat
increas
abus
sinc
implic
risk
factor
nec
addit
vasoconstrict
effect
cocain
also
shown
block
reuptak
catecholamin
nerv
termin
therebi
result
increas
circul
level
catecholamin
pregnant
women
prenat
cocain
exposur
associ
mani
advers
perinat
event
includ
stillbirth
abruptio
placenta
intrauterin
growth
retard
preterm
deliveri
sudden
infant
death
syndrom
matern
hypertens
propos
mechan
involv
increas
uterin
vascular
resist
decreas
uterin
blood
flow
chronic
placent
insuffici
accompani
fetal
hypoxemia
hypertens
tachycardia
despit
concern
studi
investig
vascular
inflammatori
effect
cocain
neonat
gi
tract
studi
pregnant
rat
expos
cocain
demonstr
sever
inflammatori
chang
uteru
placenta
gi
tract
embryo
newborn
piglet
receiv
high
dose
cocain
prolong
increas
mesenter
vascular
resist
decreas
mesenter
blood
flow
doppler
evalu
studi
use
radiolabel
techniqu
pregnant
nonpregn
rat
compar
exposur
cocain
result
signific
dosedepend
decreas
perfus
uteru
placenta
fetu
pregnant
group
chang
perfus
uteru
nonpregn
anim
retrospect
studi
involv
infant
confirm
nec
sever
differ
report
infant
without
prenat
exposur
cocain
czyrko
et
al
note
significantli
greater
need
surgic
intervent
versu
higher
incid
massiv
intestin
gangren
versu
higher
mortal
versu
infant
prenat
cocain
exposur
without
exposur
casecontrol
analysi
match
race
sex
birth
weight
demonstr
increas
risk
develop
nec
cocaineexpos
group
versu
nonexpos
group
lopez
et
al
report
incid
nec
infant
expos
cocain
compar
nonexpos
babi
addit
nec
develop
significantli
greater
number
infant
within
first
day
life
cocaineexpos
group
retrospect
cohort
studi
infant
birth
weight
g
hand
et
al
compar
infant
prenat
expos
cocain
infant
drug
exposur
signific
differ
incid
nec
two
group
despit
wellknown
advers
effect
cocain
difficult
establish
definit
causal
relationship
nec
mother
abus
cocain
pregnanc
report
illdefin
durat
extent
use
may
use
remot
time
deliveri
may
adequ
prenat
care
addit
matern
cocain
use
may
associ
use
recreat
drug
alcohol
tobacco
thu
mother
higher
risk
babi
prematur
small
gestat
age
cytokin
growth
factor
play
critic
role
mediat
prolifer
matur
chemotaxi
activ
hematopoiet
immunerel
cell
recogn
cytokin
growth
factor
import
effect
number
cell
variou
tissu
includ
gi
tract
tabl
intestin
cell
expos
cytokin
secret
intestin
endotheli
cell
mucos
fibroblast
enterocyt
epiderm
growth
factor
egf
known
import
trophic
factor
develop
gi
tract
egf
receptor
demonstr
throughout
fetal
neonat
intestin
egf
secret
gut
lumen
primarili
salivari
gland
brunner
gland
duodenum
shown
present
high
concentr
human
breast
milk
significantli
reduc
level
salivari
serum
egf
demonstr
prematur
infant
nec
develop
versu
agematch
control
inactiv
egf
receptor
knockout
mice
shown
result
hemorrhag
enter
histolog
similar
nec
studi
use
neonat
rat
model
nec
involv
exposur
asphyxia
cold
stress
enter
administ
supplement
egf
shown
significantli
decreas
incid
sever
nec
rat
pup
thu
suggest
protect
effect
may
mediat
downregul
proinflammatori
cytokin
increas
product
antiinflammatori
cytokin
fagbemi
et
al
investig
associ
nec
egf
receptor
intestin
mucosa
preterm
infant
undergo
resect
sever
nec
confirm
presenc
intact
egf
receptor
locat
basolater
membran
enterocyt
erythropoietin
epo
growth
factor
produc
kidney
regul
red
blood
cell
product
respons
anemia
sinc
develop
recombin
protein
repo
becom
wide
use
nicu
epo
found
human
breast
milk
function
epo
receptor
demonstr
fetal
neonat
small
intestin
thu
suggest
possibl
role
gi
develop
retrospect
studi
compar
vlbw
infant
receiv
repo
match
control
ledbett
juul
demonstr
significantli
lower
incid
nec
repo
group
control
group
studi
neonat
rat
given
repo
enter
demonstr
dosedepend
increas
intestin
mucos
villu
surfac
area
increas
cellular
prolifer
thu
suggest
role
repo
trophic
factor
develop
small
intestin
neonat
rat
model
nec
involv
exposur
hypoxia
reoxygen
pretreat
intraperiton
inject
repo
result
significantli
decreas
mucos
inflamm
necrosi
thought
mediat
decreas
product
nitric
oxid
cytokin
endogen
mediat
inflammatori
cascad
proinflammatori
antiinflammatori
cytokin
product
tightli
regul
complex
feedback
mechan
maintain
homeostasi
overproduct
either
may
signific
untoward
effect
overproduct
proinflammatori
cytokin
tumor
necrosi
plateletactiv
factor
paf
may
lead
shock
multiorgan
failur
death
overproduct
antiinflammatori
cytokin
may
result
excess
suppress
immun
function
number
differ
inflammatori
mediat
implic
pathogenesi
nec
vitro
studi
compar
respons
matur
human
intestin
cell
line
fetal
intestin
cell
line
inflammatori
stimul
lipopolysaccharid
lp
demonstr
exagger
secret
fetal
cell
pretreat
cell
epo
inhibit
secret
control
level
studi
evalu
serial
serum
level
two
proinflammatori
cytokin
two
antiinflammatori
cytokin
receptor
antagonist
ilra
infant
nec
edelson
et
al
demonstr
significantli
higher
level
infant
sever
nec
onset
diseas
hour
infant
less
sever
nec
note
counterregulatori
mediat
prematur
infant
secret
appropri
concentr
releas
later
onset
diseas
may
use
marker
sever
diseas
nadler
et
al
investig
pattern
cytokin
express
infant
undergo
resect
sever
nec
infant
undergo
intestin
resect
inflammatori
condit
signific
upregul
mrna
seen
specimen
infant
nec
compar
control
addit
note
signific
upregul
mrna
infant
nec
found
invers
correl
express
likelihood
pannecrosi
thu
suggest
secret
may
adapt
respons
limit
extent
intestin
damag
sever
interleukin
shown
protect
trophic
role
gi
tract
demonstr
possess
cytoprotect
effect
human
intestin
epitheli
cell
reduc
bacteri
transloc
increas
leukocyt
superoxid
product
induc
decayacceler
factor
protect
host
attack
autolog
complement
activ
known
potent
antiinflammatori
cytokin
inhibit
product
proinflammatori
cytokin
neonat
rat
hypoxiareoxygen
model
nec
recombin
administ
subcutan
found
significantli
attenu
extent
intestin
injuri
compar
control
anim
thu
suggest
protect
effect
antiinflammatori
properti
shown
pleiotrop
cytokin
promot
epitheli
regener
enhanc
adapt
bowel
resect
subcutan
administr
recombin
rat
undergo
placement
defunction
thiryvella
loop
intestin
massiv
small
bowel
resect
result
prevent
mucos
atrophi
defunction
loop
enhanc
mucos
adapt
absorpt
function
remain
intestin
resect
tremend
amount
investig
perform
defin
role
pathogenesi
number
differ
inflammatori
process
evid
support
possibl
dichotom
function
benefici
detriment
molecul
especi
regard
gi
tract
produc
arginin
three
isoform
nitric
oxid
synthas
no
neuron
nno
endotheli
eno
constitut
present
low
level
small
intestin
induc
ino
form
induc
respons
inflammatori
cytokin
constitut
form
no
constitut
level
demonstr
modul
number
import
function
gi
tract
includ
mainten
mucos
integr
regul
mucos
permeabl
blood
flow
regul
motil
inhibit
leukocyt
adhes
activ
inhibit
synthesi
varieti
anim
model
intestin
injuri
induc
ischemiareperfus
lp
paf
result
mark
exacerb
mucos
injuri
administr
exogen
sourc
includ
larginin
sodium
nitroprussid
nitroglycerin
greatli
attenu
detriment
effect
prospect
studi
prematur
infant
zamora
et
al
demonstr
significantli
lower
plasma
arginin
level
time
diagnosi
infant
nec
develop
control
random
prospect
placebocontrol
studi
vlbw
infant
assign
receiv
either
daili
oral
parenter
larginin
supplement
mgkg
placebo
first
day
life
amin
et
al
found
significantli
lower
incid
nec
supplement
group
control
group
throughout
studi
group
receiv
arginin
supplement
significantli
higher
mean
plasma
arginin
level
control
group
interestingli
group
infant
nec
develop
significantli
lower
plasma
arginin
level
time
diagnosi
respect
peer
known
whether
decreas
arginin
level
repres
increas
util
product
consumpt
synthesi
protein
decreas
enter
absorpt
studi
suggest
possibl
benefit
arginin
supplement
potenti
donor
prevent
nec
induc
form
synthas
ino
known
upregul
respons
inflammatori
cytokin
within
sever
hour
stimul
express
activ
within
intestin
epithelium
increas
result
product
larg
amount
although
low
level
produc
constitut
isoform
no
may
play
homeostat
role
gi
tract
sustain
releas
result
upregul
suggest
deleteri
effect
induc
cellular
injuri
failur
mucos
barrier
thought
occur
reaction
excess
superoxid
produc
peroxynitrit
onoo
potent
reactiv
nitrogen
intermedi
may
trigger
cytotox
process
includ
lipid
peroxid
dna
damag
prospect
studi
investig
express
intestin
infant
undergo
resect
nec
ford
et
al
demonstr
mark
upregul
gene
express
intestin
epithelium
increas
apoptosi
enterocyt
apic
villi
addit
increas
level
nitrotyrosin
residu
detect
apic
villi
thu
suggest
mucos
injuri
increas
apoptosi
mediat
format
peroxynitrit
neonat
rat
hypoxia
model
nec
breast
milkf
anim
compar
formulaf
anim
nadler
et
al
demonstr
significantli
higher
incid
nec
express
enterocyt
apoptosi
decreas
mrna
formulaf
group
breast
milkf
group
decreas
express
thought
mediat
theoriz
contribut
intestin
injuri
attenu
bacteri
clearanc
paf
endogen
phospholipid
inflammatori
mediat
shown
play
import
role
pathophysiolog
intestin
injuri
anim
human
studi
paf
divers
biolog
effect
includ
mesenter
vasoconstrict
capillari
leakag
increas
intestin
mucos
permeabl
neutrophil
platelet
activ
clinic
increas
paf
level
demonstr
formulaf
prematur
infant
well
nec
develop
neonat
rat
model
nec
caplan
et
al
shown
intestin
paf
concentr
intestin
phospholipas
pafsynthes
enzym
mrna
express
intestin
paf
receptor
mrna
express
elev
anim
experi
exogen
paf
administr
result
sever
bowel
necrosi
endogen
intestin
product
paf
upregul
respons
variou
stimuli
includ
lp
hypoxia
administr
paf
receptor
antagonist
paf
acetylhydrolas
pafdegrad
enzym
reduc
risk
nec
human
studi
paf
acetylhydrolas
activ
demonstr
present
human
breast
milk
shown
decreas
neonat
level
approach
adult
enzym
activ
around
week
life
found
defici
infant
nec
prospect
studi
infant
risk
nec
rabinowitz
et
al
monitor
serial
plasma
level
paf
pafrel
lipid
pafll
investig
chang
occur
nec
significantli
higher
peak
pafll
level
infant
nec
develop
control
addit
rise
pafll
level
posit
correl
progress
sever
nec
level
return
baselin
level
recoveri
mani
proinflammatori
effect
includ
neutrophil
activ
induct
leukocyt
endotheli
adhes
molecul
induct
cytokin
paf
demonstr
produc
profound
hypotens
sever
intestin
necrosi
similar
nec
anim
effect
shown
mediat
paf
attenu
paf
receptor
antagonist
lp
endotoxin
bacteri
product
capac
produc
potent
inflammatori
respons
induct
variou
proinflammatori
cytokin
paf
tnf
system
inject
lp
shown
produc
hypotens
shock
sever
intestin
necrosi
use
anim
model
nec
reliabl
gener
intestin
injuri
resembl
nec
lpsinduc
intestin
injuri
demonstr
mediat
paf
prevent
paf
antagonist
cyclooxygenas
cox
catalyz
ratelimit
step
arachidon
acid
metabol
prostaglandin
leukotrien
thromboxan
two
isoform
cox
enzym
identifi
constitut
express
mani
tissu
includ
gi
tract
induc
form
express
inflammatori
condit
gi
tract
inflammatori
bowel
diseas
proinflammatori
cytokin
well
proinflammatori
transcript
factor
nuclear
shown
increas
express
import
protein
activ
number
inflammatori
mediat
cytokin
mark
increas
express
demonstr
intestin
resect
infant
sever
nec
elucid
mechan
involv
express
nec
chung
et
al
neonat
rat
model
nec
demonstr
coordin
induct
activ
express
earli
phase
injuri
event
despit
mani
year
extens
investig
identif
sever
risk
factor
pathogenesi
nec
remain
elus
etiolog
probabl
multifactori
involv
combin
mucos
compromis
pathogen
bacteria
feed
suscept
host
result
bowel
injuri
inflammatori
cascad
risk
factor
prematur
consist
import
anoth
import
risk
factor
involv
enter
feed
formula
commerci
avail
formula
lack
mani
benefici
properti
present
breast
milk
protect
agent
includ
gut
trophic
hormon
factor
induc
intestin
matur
factor
enhanc
colon
nonvirul
bacteria
antiinflammatori
mediat
vitamin
antioxid
compon
provid
cellular
humor
immun
evid
impair
gut
barrier
preterm
gi
tract
character
immatur
cellular
humor
immun
increas
permeabl
reduc
gastric
acid
secret
reduc
concentr
proteolyt
enzym
incomplet
innerv
decreas
motil
immatur
intestin
epithelium
microvilli
decreas
barrier
function
evid
otherwis
healthi
preterm
infant
abil
system
absorb
deliv
undigest
macromolecul
whole
bacteria
lp
compromis
intestin
epitheli
mucos
barrier
appear
first
event
lead
activ
inflammatori
cascad
reduc
mucos
blood
flow
lead
cellular
hypoxia
injuri
one
frequent
cite
etiolog
factor
nec
touloukian
emphas
high
incid
perinat
physiolog
stressor
may
primarili
secondarili
caus
intestin
ischemia
chief
among
factor
hypox
hypotens
episod
exchang
transfus
umbil
vein
umbil
arteri
cathet
cardiovascular
lesion
serum
hyperviscos
atavist
dive
reflex
blood
preferenti
divert
away
splanchnic
circul
order
maintain
adequ
perfus
heart
brain
hypothes
occur
episod
period
low
blood
flow
subsequ
reperfus
park
et
al
found
reaction
xanthin
oxidas
hypoxanthin
molecular
oxygen
result
burst
superoxid
radic
product
free
radic
may
caus
damag
cellular
mitochondri
membran
alter
permeabl
intestin
mucos
barrier
although
anim
studi
provid
support
theori
clinic
correl
lack
prospect
clinic
trial
abl
consist
establish
associ
hypox
event
develop
nec
extens
investig
critic
role
variou
inflammatori
mediat
pathogenesi
nec
conduct
studi
anim
model
human
specimen
identifi
paf
lp
potenti
mediat
diseas
effect
lp
shown
mediat
paf
increas
mucos
permeabl
suscept
allow
transloc
bacteria
bacteri
toxin
activ
inflammatori
cascad
thought
critic
step
lead
final
collaps
intestin
epitheli
integr
littl
known
earli
chain
event
occur
onset
tissu
damag
recent
studi
suggest
disrupt
intestin
mucos
barrier
result
acceler
apoptosi
key
mediat
identifi
nec
paf
lp
shown
caus
apoptosi
intestin
epitheli
cell
neonat
rat
model
nec
involv
formulaf
anim
expos
hypoxia
cold
stress
motherf
control
jill
et
al
demonstr
mark
increas
apoptosi
epitheli
layer
nec
group
comparison
control
although
mechan
undetermin
acceler
apoptosi
shown
preced
gross
morpholog
chang
intestin
epithelium
administr
pancaspas
inhibitor
inhibit
intestin
apoptosi
result
significantli
reduc
rate
epitheli
apoptosi
well
decreas
incid
nec
thu
suggest
apoptosi
underli
caus
subsequ
mucos
damag
ultim
lead
nec
sustain
overproduct
upregul
gi
tract
respons
inflammatori
stimulu
suggest
induc
cellular
injuri
disrupt
intestin
epitheli
barrier
product
potent
oxid
peroxynitrit
ford
et
al
demonstr
upregul
intestin
wall
infant
nec
increas
apoptosi
enterocyt
mediat
peroxynitrit
acceler
apoptosi
thought
result
bare
area
villu
tip
repres
break
intestin
mucos
barrier
bacteria
may
attach
transloc
initi
inflammatori
cascad
addit
peroxynitrit
also
shown
inhibit
prolifer
intestin
epitheli
cell
rat
model
nec
data
suggest
condit
associ
sustain
overproduct
peroxynitrit
eg
nec
intestin
epitheli
barrier
dysfunct
may
result
imbal
caus
acceler
epitheli
injuri
blunt
tissu
repair
mechan
type
feed
pattern
intestin
colon
may
determin
risk
develop
nec
breastfeed
infant
becom
colon
predominantli
bifidobacteria
gramposit
bacteria
help
control
growth
gramneg
bacteria
contrast
formulaf
infant
becom
colon
predominantli
coliform
enterococci
bacteroid
speci
import
bacteria
pathogenesi
nec
support
follow
evid
nec
occur
episod
epidem
wave
affect
patient
relat
place
time
infecti
agent
initi
infect
control
measur
shown
stop
epidem
cluster
occurr
ident
microorgan
isol
afflict
babi
caretak
nec
occur
infant
known
risk
factor
nec
develop
sever
week
month
perinat
insult
gi
tract
fulli
colon
suffici
time
recov
perinat
insult
administr
larg
dose
vitamin
e
interfer
intracellular
kill
bacteria
leukocyt
prematur
infant
link
increas
incid
nec
neclik
diseas
occur
vulner
host
ingest
clostridium
speci
lesion
resembl
nec
reproduc
experiment
administr
lp
endotoxemia
demonstr
nec
posit
blood
cultur
gramneg
bacteria
pneumatosi
intestinali
common
radiograph
find
repres
submucos
ga
collect
produc
bacteri
ferment
follow
common
clinic
scenario
support
unifi
hypothesi
pathogenesi
nec
prematur
infant
admit
nicu
usual
treatment
necrot
enterocol
respiratori
distress
expos
potenti
pathogen
nosocomi
flora
infant
may
experi
intermitt
episod
apnea
bradycardia
broadspectrum
antibiot
routin
administ
elimin
infant
anaerob
flora
normal
function
barrier
colon
overgrowth
potenti
pathogen
gramneg
organ
instead
breast
milk
formula
feed
usual
administ
formula
provid
substrat
bacteri
growth
contain
none
protect
factor
present
breast
milk
poor
peristalsi
gi
tract
permit
overgrowth
pathogen
bacteria
depend
quantiti
virul
microorgan
presenc
absenc
mucos
damag
bacteria
may
breach
mucos
barrier
defici
specif
nonspecif
immun
defens
bacteri
kill
ineffect
either
episod
decreas
perfus
reperfus
mild
infect
mucos
barrier
damag
proinflammatori
cytokin
induc
result
initi
inflammatori
cascad
cascad
lead
increas
mucos
permeabl
turn
caus
damag
mucosa
bowel
wall
bacteria
bacteri
byproduct
invad
mucos
break
progress
bowel
damag
result
fullthick
necrosi
perfor
nec
may
involv
singl
multipl
discontinu
segment
intestin
commonli
termin
ileum
follow
colon
involv
larg
small
intestin
occur
case
paninvolv
pannecrosi
nec
totali
fulmin
form
nec
character
necrosi
least
gut
account
case
surgic
treat
nec
death
surgeri
gross
appear
nec
fairli
constant
bowel
markedli
distend
patchi
area
thin
seros
surfac
typic
red
gray
may
cover
fibrin
exud
frank
gangren
seros
surfac
black
subseros
ga
collect
frequent
encount
mucos
surfac
may
ulcer
wide
area
epitheli
slough
bloodi
periton
fluid
seen
bowel
necrosi
present
brown
turbid
fluid
seen
perfor
occur
bowel
inflamm
nearli
ubiquit
nec
fig
degre
natur
howev
vari
one
area
anoth
acut
chronic
inflammatori
chang
coexist
case
common
microscop
lesion
bland
coagul
necrosi
superfici
mucosa
edema
hemorrhag
submucosa
follow
complet
mucos
necrosi
fig
pneumatosi
intestinali
initi
seen
submucosa
later
musculari
subserosa
bacteria
bowel
lumen
wall
present
case
occasion
found
ga
cyst
transmur
necrosi
character
hyalin
eosinophilia
loss
nuclear
detail
muscular
layer
present
advanc
diseas
epitheli
regener
format
granul
tissu
earli
fibrosi
often
present
suggest
suppur
process
last
least
day
granul
tissu
mucos
submucos
fibrosi
may
seen
adjac
area
activ
mucos
submucos
necrosi
may
account
part
late
strictur
format
thrombi
sometim
note
small
mesenter
vessel
small
arteriol
submucosa
smallvessel
thrombosi
within
necrot
tissu
consid
secondari
chang
largevessel
thrombosi
rel
rare
find
autopsi
nec
commonli
herald
nonspecif
clinic
find
simpli
repres
physiolog
instabl
find
includ
lethargi
temperatur
instabl
recurr
apnea
bradycardia
hypoglycemia
shock
specif
symptom
relat
gi
tract
includ
abdomin
distent
blood
per
rectum
high
gastric
residu
feed
vomit
diarrhea
gross
blood
stool
present
case
occult
blood
rectal
bleed
seldom
massiv
spectrum
diseas
sever
vari
physic
examin
may
initi
demonstr
subtl
abdomin
distent
minim
tender
diseas
progress
abdomin
palpat
may
elicit
tender
demonstr
palpabl
bowel
loop
fix
mobil
mass
abdomin
wall
crepitu
edema
erythema
abdomin
wall
result
underli
periton
present
initi
approxim
case
common
later
cours
diseas
male
may
discolor
scrotum
indic
perfor
small
subset
patient
diseas
rapidli
progress
initi
manifest
herald
florid
clinic
find
death
within
hour
infant
nec
usual
neutropenia
thrombocytopenia
metabol
acidosi
total
leukocyt
count
may
elev
gener
low
one
studi
infant
absolut
neutrophil
count
less
cellsmm
infant
lowest
count
studi
worst
prognosi
neutrophil
count
less
cellsmm
commonli
associ
concomit
gramneg
septicemia
thrombocytopenia
nearli
univers
present
seem
associ
gramneg
sepsi
platelet
bind
endotoxin
incid
thrombocytopenia
nec
essenti
unchang
earliest
report
oneil
demonstr
cohort
infant
underw
surgeri
nec
platelet
count
less
cellsmm
row
et
al
found
platelet
count
less
cellsmm
present
patient
posit
cultur
gramneg
organ
nadir
platelet
count
cours
diseas
note
lower
patient
sever
diseas
die
platelet
count
less
l
rapid
fall
poor
prognost
indic
metabol
acidosi
common
patient
nec
believ
result
hypovolemia
sepsi
specif
indic
intestin
necrosi
stool
sampl
commonli
posit
occult
blood
reduc
substanc
book
et
al
reason
intestin
mucos
damag
nec
lead
carbohydr
malabsorpt
poorli
digest
carbohydr
pass
colon
ferment
excret
stool
author
test
stool
formulaf
infant
reduc
substanc
clinitest
tablet
found
formulaf
infant
nec
develop
greater
reduc
substanc
stool
colon
bacteri
ferment
increas
local
product
dlactat
absorb
excret
kidney
garcia
et
al
could
show
elev
urinari
dlactat
level
infant
nec
control
infant
recoveri
nec
administr
enter
antibiot
dlactat
excret
decreas
similarli
hydrogen
excret
breath
elev
ferment
increas
test
help
rule
nec
neg
result
breath
hydrogen
test
accur
rule
nec
creactiv
protein
crp
acut
phase
reactant
measur
attempt
correl
level
presenc
absenc
resolut
diseas
crp
may
serv
earli
indic
nec
level
rise
mgl
within
hour
suspect
diagnosi
report
sensit
specif
failur
crp
return
normal
within
day
indic
abscess
strictur
septicemia
prove
extrem
difficult
identifi
common
offend
infecti
agent
organ
recov
blood
stool
patient
nec
vari
depend
gi
tract
flora
nosocomi
flora
site
cultur
durat
previou
antibiot
therapi
unclear
whether
bacteria
cultur
repres
pathogen
caus
nec
instead
secondari
opportunist
invad
select
antibiot
regimen
furthermor
lack
suffici
match
control
complet
bacteriolog
data
patient
similar
environ
make
studi
microbiolog
nec
difficult
bacteriolog
data
nec
primarili
base
cultur
obtain
blood
stool
periton
caviti
blood
cultur
posit
patient
contrast
bacteria
data
implic
fungu
initi
organ
pathogenesi
nec
fungi
believ
secondari
invad
nation
institut
child
health
human
develop
neonat
research
network
studi
nec
report
blood
cultur
posit
fungu
necrot
enterocol
karlowicz
report
increas
fungal
periton
institut
fungal
septicemia
candida
speci
implic
mani
late
nec
death
retrospect
premortem
postmortem
examin
bodi
fluid
tissu
cultur
patient
die
nec
smith
et
al
patient
evid
fungu
colon
found
first
posit
cultur
obtain
mean
day
surgeri
eight
patient
fungal
sepsi
seven
candida
speci
one
torulopsi
speci
first
posit
fungal
cultur
obtain
day
surgeri
fungal
sepsi
diagnos
death
four
eight
patient
mucos
injuri
may
mediat
toxin
case
nec
toxin
produc
c
difficil
c
butyricum
e
coli
isol
stool
sampl
epidem
studi
scheifel
et
al
demonstr
delta
toxin
elabor
coagulaseneg
staphylococci
present
stool
coagulaseneg
staphylococc
case
nec
toxin
rare
found
patient
colon
coagulaseneg
staphylococci
without
nec
larg
seri
sporad
case
follow
sudden
appear
cluster
rel
larg
number
case
mani
epidem
specif
pathogen
identifi
book
et
al
part
ongo
nosocomi
infect
surveil
program
prospect
studi
infant
nec
develop
six
tempor
geograph
relat
cluster
case
nec
occur
specif
organ
isol
episod
nurseri
personnel
experienc
concomit
acut
gi
ill
implement
infect
control
measur
associ
signific
decreas
rate
nec
similar
epidem
without
specif
pathogen
note
rainbow
babi
children
hospit
children
hospit
philadelphia
sporad
case
nec
occur
pathogen
identifi
stool
infant
nurseri
van
acker
et
al
report
outbreak
nec
infant
period
associ
enterobact
sakazakii
pathogen
found
contamin
powder
milk
formula
use
nicu
epidem
outbreak
identifi
e
coli
salmonella
speci
c
difficil
rotaviru
coronaviruslik
organ
cornerston
diagnosi
nec
plain
anteroposterior
left
later
decubitu
radiograph
follow
find
associ
nec
ileu
pattern
nonspecif
bowel
distent
pneumatosi
intestinali
linear
cystic
fig
portal
vein
ga
pneumoperitoneum
intraperiton
fluid
persist
dilat
fix
loop
pneumatosi
portal
vein
ga
often
fleet
sign
multipl
gasfil
loop
intestin
earliest
common
radiolog
find
patient
nec
case
fluid
air
accumul
airfluid
level
visibl
decubitu
view
degre
dilat
distribut
bowel
loop
relat
clinic
sever
progress
diseas
case
nonspecif
intestin
dilat
preced
clinic
symptom
suggest
nec
sever
hour
demonstr
pneumatosi
intestinali
intramur
ga
appropri
clinic
set
diagnost
nec
air
mainli
compris
hydrogen
byproduct
bacteri
metabol
frequenc
pneumatosi
intestinali
rang
although
may
absent
patient
nec
even
sever
diseas
convers
extens
pneumatosi
may
present
minim
sign
often
respond
promptli
medic
manag
pneumatosi
fleet
may
appear
onset
clinic
symptom
commonli
earli
rather
late
find
frequent
note
infant
fed
contrast
unf
babi
pneumatosi
intestinali
specif
nec
note
infant
enterocol
hirschsprung
diseas
inspiss
milk
syndrom
pylor
stenosi
sever
diarrhea
carbohydr
intoler
disord
two
form
pneumatosi
intestinali
recogn
radiograph
cystic
linear
cystic
form
granular
foami
appear
repres
ga
submucosa
often
confus
fecal
materi
larg
intestin
linear
pneumatosi
consist
small
bubbl
collect
within
musculari
subserosa
form
thin
linear
curvilinear
ga
pattern
outlin
wall
segment
intestin
portal
vein
ga
appear
linear
branch
radioluc
overli
liver
often
extend
peripheri
repres
ga
dispers
fine
radicl
portal
venou
system
presenc
portal
vein
ga
fleet
perhap
account
low
report
incid
seri
presenc
portal
vein
ga
associ
poor
prognosi
case
paninvolv
ga
present
patient
genesi
portal
vein
ga
may
involv
accumul
ga
bowel
wall
result
bacteri
invas
dissect
venou
system
migrat
radicl
portal
vein
altern
may
repres
action
gasform
bacteria
within
portal
venou
system
free
air
periton
caviti
associ
perfor
intestin
demonstr
patient
best
note
left
later
decubitu
crosstabl
later
view
upright
radiographi
unnecessari
supin
view
abdomen
demonstr
free
air
outlin
falciform
ligament
footbal
sign
umbil
arteri
urach
remnant
reveal
doubl
wall
sign
sign
refer
visual
air
side
wall
lumen
periton
caviti
patient
intestin
perfor
prove
surgeri
radiograph
evid
show
free
air
thu
demonstr
perfor
occur
surprisingli
high
number
patient
without
evid
free
air
one
must
keep
mind
pneumoperitoneum
may
occur
without
intestin
perfor
mechan
ventil
sever
lung
diseas
clinic
situat
barotrauma
may
produc
alveolar
ruptur
air
dissect
abdomen
mediastinum
patient
sign
symptom
laboratori
find
often
differenti
caus
air
one
unsur
abdomin
paracentesi
may
perform
aspir
fluid
analyz
ascit
watersolubl
contrast
studi
via
gastric
tube
may
perform
rule
gastric
perfor
sever
plain
radiograph
find
suggest
free
fluid
periton
caviti
amen
paracentesi
grossli
distend
abdomen
devoid
ga
gasfil
loop
bowel
center
abdomen
surround
opac
flank
increas
hazi
within
abdomen
separ
bowel
loop
find
report
case
ascit
portal
vein
ga
radiograph
find
associ
high
mortal
rate
twentyon
percent
patient
surgic
proven
intestin
perfor
ascit
howev
patient
proven
intestin
perfor
neither
ascit
free
air
plain
radiograph
persist
dilat
loop
sign
plain
radiograph
find
describ
wexler
studi
five
babi
nec
singl
loop
sever
loop
dilat
bowel
remain
unchang
posit
configur
hour
fullthick
necrosi
subsequ
develop
patient
find
howev
alway
indic
bowel
necrosi
leonard
et
al
found
persist
loop
patient
proven
nec
fiftyseven
percent
infant
persist
loop
necrot
intestin
surgeri
autopsi
necrosi
never
develop
recov
nonop
treatment
radiopaqu
contrast
studi
upper
gi
tract
may
occasion
use
improv
diagnost
accuraci
patient
equivoc
clinic
radiolog
sign
nec
howev
overdiagnosi
contrast
radiographi
possibl
may
lead
unwarr
treatment
care
attent
type
contrast
agent
use
studi
critic
barium
never
use
extravas
barium
stool
mixtur
perfor
may
intensifi
periton
unlik
barium
watersolubl
contrast
agent
absorb
bowel
periton
caviti
practic
implic
absorpt
transient
hour
increas
urinari
specif
graviti
histor
watersolubl
agent
hyperosmolar
caus
danger
larg
intralumin
fluid
shift
especi
prematur
patient
current
watersolubl
agent
nonion
much
lower
osmolar
produc
excel
opacif
gi
tract
nec
suspect
intestin
contrast
enhanc
demonstr
bowel
wall
loop
separ
edemat
wall
irregular
mucosa
illdefin
margin
mucos
ulcer
bowel
wall
spicul
pneumatosi
intestinali
examin
may
perform
bedsid
though
advoc
contrast
enema
perform
risk
rectosigmoid
perfor
unless
colon
diseas
reflux
necrot
enterocol
contrast
diseas
distal
ileum
contrast
enema
diagnost
nec
may
fact
overdiagnos
nec
contrast
enema
shown
produc
pneumatosi
transient
portal
venou
air
unlik
bedsid
upper
gi
seri
contrast
enema
must
perform
simultan
fluoroscopi
necessit
transfer
critic
ill
neonat
radiolog
suit
infant
recent
complet
cours
therapi
nec
sign
partial
small
bowel
obstruct
bloodting
stool
develop
contrast
enema
use
identifi
strictur
ultrasonographi
us
use
identifi
necrot
bowel
intraperiton
fluid
portal
venou
air
theoret
us
may
signific
valu
identifi
patient
requir
surgeri
sensit
time
manner
possibl
convent
clinic
radiograph
method
abnorm
bowel
loop
us
character
hypoecho
rim
central
echogen
focu
target
sign
pericholecyst
hyperechogen
believ
repres
either
pericholecyst
venou
ga
extens
foami
inflammatori
infiltr
nec
pericholecyst
space
describ
avni
et
al
use
us
diagnosi
nec
applic
patient
question
clinic
radiolog
find
local
intraabdomin
fluid
paracentesi
magnet
reson
imag
mri
noninvas
modal
recent
use
identifi
infant
ischem
bowel
secondari
nec
although
mri
capabl
demonstr
cardin
find
nec
need
use
studi
limit
select
appropri
treatment
nonop
versu
oper
determin
impact
therapi
surviv
late
outcom
essenti
investig
use
compar
criteria
classifi
stage
nec
sever
classif
scheme
propos
bell
et
al
introduc
commonli
use
classif
threestag
system
suspect
definit
advanc
categor
patient
histor
factor
gi
manifest
radiolog
find
system
sign
tabl
bell
stage
criteria
modifi
three
stage
still
use
subset
includ
effort
identifi
specif
prognost
factor
infant
stage
diseas
featur
suggest
nec
patient
stage
ii
diseas
definit
nec
without
indic
surgic
intervent
patient
stage
iii
diseas
advanc
nec
evid
bowel
necrosi
perfor
absenc
intestin
necrosi
perfor
mainstay
treatment
patient
nec
support
feed
stop
gi
tract
decompress
sump
gastric
tube
intraven
fluid
resuscit
initi
complet
blood
count
platelet
count
blood
ga
analysi
crp
serum
electrolyt
level
obtain
blood
urin
sampl
sent
cultur
broadspectrum
intraven
antibiot
therapi
initi
recent
antibiot
regimen
includ
penicillin
aminoglycosid
agent
effect
anaerob
organ
seem
logic
coverag
anaerob
organ
includ
infant
usual
week
old
care
perform
studi
anaerob
spars
date
control
studi
shown
efficaci
therapi
antibiot
regimen
best
tailor
common
organ
found
nec
also
nosocomi
nurseri
flora
recent
report
patient
stool
blood
cultur
posit
coagulaseneg
staphylococci
group
empir
treat
patient
combin
vancomycin
gentamicin
vancomycin
thirdgener
cephalosporin
incid
fungal
sepsi
infant
die
nec
high
strong
index
suspicion
must
maintain
empir
antifung
therapi
consid
patient
continu
symptomat
without
obviou
bacteri
caus
close
clinic
observ
consist
frequent
physic
examin
twoview
abdomin
radiographi
perform
everi
hour
serum
platelet
leukocyt
count
blood
ga
analysi
feed
resum
stool
test
reduc
substanc
occult
blood
feed
discontinu
result
either
test
becom
posit
patient
definit
diseas
moder
sever
bell
stage
ii
treat
bowel
rest
decompress
antibiot
therapi
least
day
central
venou
cathet
may
place
total
parenter
nutrit
patient
clinic
well
small
amount
dilut
formula
may
restart
infant
constantli
care
monitor
abdomin
distent
vomit
nonspecif
sign
symptom
nec
feed
progress
slowli
goal
volum
avoid
use
concentr
formula
largevolum
feed
infant
undergon
surgeri
receiv
week
postop
intraven
antibiot
feed
initi
patient
clinic
well
return
bowel
function
establish
princip
goal
surgic
intervent
set
nec
remov
gangren
bowel
preserv
intestin
length
ideal
surgeri
undertaken
gangren
present
perform
perfor
occur
unfortun
combin
clinic
examin
adjunct
test
shown
high
sensit
intestin
gangren
thu
remain
controversi
regard
indic
surgeri
appropri
time
intervent
optim
surgic
treatment
strategi
wide
accept
indic
surgeri
presenc
pneumoperitoneum
attempt
identifi
characterist
may
serv
predictor
intestin
gangren
koslosk
review
criteria
use
indic
surgeri
patient
nec
stratifi
criteria
accord
sensit
specif
positiveneg
predict
valu
preval
best
indic
specif
posit
predict
valu
ppv
approach
preval
pneumoperitoneum
posit
paracentesi
aspir
ml
brown
yellow
fluid
contain
bacteria
gram
stain
portal
venou
ga
good
indic
specif
ppv
approach
preval
fix
intestin
loop
erythema
abdomin
wall
palpabl
abdomin
mass
fair
indic
specif
ppv
preval
sever
pneumatosi
intestinali
grade
radiograph
system
poorer
indic
clinic
deterior
ppv
platelet
count
lower
ppv
abdomin
tender
ppv
sever
gi
hemorrhag
ppv
gasless
abdomen
ascit
unfortun
none
indic
sensit
greater
current
absolut
indic
surgeri
pneumoperitoneum
rel
indic
includ
posit
paracentesi
palpabl
abdomin
mass
abdomin
wall
erythema
portal
venou
ga
fix
intestin
loop
clinic
deterior
despit
maxim
medic
therapi
infant
pneumoperitoneum
develop
nonop
treatment
undergo
either
laparotomi
periton
drain
placement
unfortun
pneumoperitoneum
alway
demonstr
neonat
gut
perfor
one
studi
report
infant
perfor
demonstr
free
air
paracentesi
posit
result
paracentesi
defin
freeflow
aspir
ml
brown
yellowbrown
fluid
contain
bacteria
gram
stain
highli
specif
intestin
necrosi
neg
result
paracentesi
rare
intestin
necrosi
occur
local
walledoff
perfor
present
segment
bowel
injur
perfor
absolut
indic
paracentesi
koslosk
recommend
abdomin
paracentesi
patient
extens
pneumatosi
intestinali
improv
nonop
manag
periton
fluid
aspir
periton
lavag
perform
instil
mlkg
normal
salin
solut
periton
caviti
turn
patient
side
side
withdraw
fluid
rickett
jerl
report
greater
surviv
rate
posit
result
abdomin
paracentesi
use
indic
surgeri
patient
three
fals
neg
occur
perform
paracentesi
erythema
edema
abdomin
wall
portal
vein
ga
fix
dilat
loop
sequenti
abdomin
radiographi
fix
tender
abdomin
mass
persist
clinic
deterior
indic
use
paracentesi
report
consid
indic
surgeri
mani
surgeon
determin
signific
portal
vein
ga
relat
presenc
extent
bowel
necrosi
mortal
kurkchubasch
et
al
review
experi
children
hospit
pittsburgh
well
world
literatur
patient
collect
portal
vein
ga
plain
radiographi
patient
underw
surgeri
usual
hour
radiograph
appear
portal
vein
ga
patient
fullthick
bowel
necrosi
necrosi
length
entir
small
intestin
overal
surgic
mortal
rate
patient
portal
vein
ga
paninvolv
die
patient
portal
vein
ga
undergo
surgeri
bowel
necrosi
requir
surgeri
develop
die
separ
studi
row
et
al
suggest
intestin
necrosi
develop
infant
portal
venou
ga
paninvolv
develop
recent
review
infant
nec
portal
venou
ga
molik
et
al
report
overal
oper
mortal
paninvolv
necrot
enterocol
fix
dilat
intestin
loop
defin
persist
locat
configur
hour
approxim
half
patient
recov
without
oper
laparoscopi
use
assess
two
patient
dilat
intestin
loop
nec
confirm
one
case
rule
mani
criteria
oper
children
show
continu
clinic
deterior
despit
adequ
support
therapi
none
absolut
indic
criteria
includ
abdomin
wall
erythema
periton
physic
examin
persistentincreas
acidosi
persistentprogress
thrombocytopenia
mention
pneumoperitoneum
may
alway
evid
intestin
perfor
gasless
abdomen
suggest
fluidfil
abdomin
caviti
may
indic
perfor
frey
et
al
report
infant
intestin
perfor
radiograph
evid
ascit
note
radiograph
imprecis
evid
ascit
appropri
clinic
set
nec
mandat
paracentesi
evalu
advanc
diseas
requir
surgic
intervent
develop
infant
nec
lack
qualiti
prospect
random
trial
optim
surgic
treatment
strategi
nec
remain
controversi
goal
surgeri
remov
gangren
bowel
preserv
intestin
length
within
context
number
differ
option
exist
agre
surgic
approach
determin
extent
intestin
involv
patient
gener
condit
optim
surgeri
aggress
ventilatori
support
treatment
shock
administr
broadspectrum
antibiot
correct
anemia
coagulopathi
ideal
minimum
urin
output
mlkghr
ageappropri
mean
arteri
pressur
achiev
oper
procedur
may
perform
nicu
appropri
condit
without
increas
complic
treatment
intestin
perfor
vlbw
infant
remain
controversi
ein
et
al
report
use
periton
drainag
pd
mean
stabil
improv
system
statu
prematur
infant
perfor
laparotomi
sinc
primari
treatment
pd
use
varieti
set
investig
suggest
may
serv
definit
therapi
prospect
studi
involv
infant
treat
pd
primari
manag
advanc
nec
demestr
et
al
report
patient
treat
pd
patient
requir
laparotomi
pd
surviv
rate
pd
although
demonstr
improv
drainag
pd
infant
requir
delay
surgeri
morgan
et
al
use
pd
primari
treatment
nec
perfor
infant
weigh
less
g
unstabl
babi
heavier
g
report
surviv
rate
pd
survivor
requir
oper
intervent
moss
et
al
recent
perform
metaanalysi
pd
versu
laparotomi
perfor
nec
review
publish
studi
topic
mark
bia
treatment
assign
greater
proport
smaller
babi
undergo
pd
versu
laparotomi
author
unabl
determin
rel
merit
pd
current
surgeon
propos
pd
initi
treatment
vlbw
infant
perfor
nec
allow
resuscit
stabil
definit
laparotomi
attempt
address
issu
two
multicent
prospect
random
control
trial
current
progress
compar
pd
primari
laparotomi
prematur
infant
less
g
pierro
net
trial
less
g
rl
moss
necstep
trial
laparotomi
extent
nec
may
classifi
focal
multifoc
panintestin
viabl
bowel
depend
diseas
patient
characterist
time
surgeri
number
differ
surgic
option
may
undertaken
includ
resect
enterostomi
resect
anastomosi
proxim
enterostomi
clip
drop
techniqu
patch
drain
wait
techniqu
abdomen
enter
via
right
transvers
supraumbil
incis
precaut
taken
injur
liver
sampl
periton
fluid
may
harvest
cultur
aerob
anaerob
fungal
organ
entir
gi
tract
systemat
examin
assess
extent
diseas
viabil
bowel
conclus
procedur
one
record
length
viabl
intestin
remain
note
presenc
absenc
ileocec
valv
rare
cite
complic
laparotomi
nec
spontan
intraop
liver
hemorrhag
injuri
caus
retractor
finger
dissect
vanderkolk
et
al
report
complic
oper
nec
period
mean
gestat
age
liver
hemorrhag
week
mean
weight
g
one
patient
surviv
author
identifi
low
mean
preoper
arteri
pressur
high
preoper
fluid
administr
preced
hour
signific
predispos
factor
complic
occur
shortli
abdomen
open
intestin
eviscer
liver
congest
follow
subcapsular
hematoma
free
ruptur
singl
area
bowel
necrot
perfor
limit
resect
necessari
creation
proxim
enterostomi
distal
mucu
fistula
standard
care
prefer
exterior
stoma
wound
either
juxtapos
separ
mesenteri
often
thick
foreshorten
thu
make
passag
stoma
blood
suppli
abdomin
wall
difficult
stoma
closur
facilit
incid
wound
complic
increas
comparison
stoma
remot
locat
enterostomi
creat
sutur
intestin
fascia
interrupt
sutur
cm
bowel
left
protrud
abdomin
wall
attempt
made
use
sutur
matur
end
intestin
stoma
viabil
question
surgeri
small
portion
full
thick
intestin
excis
bedsid
cut
end
observ
bleed
resect
primari
anastomosi
isol
diseas
may
perform
care
select
patient
propon
primari
anastomosi
cite
high
morbid
associ
enterostomi
infant
need
second
oper
safe
perform
techniqu
follow
criteria
must
met
sharpli
local
usual
proxim
segment
diseas
undamag
appear
remain
intestin
good
overal
patient
condit
without
evid
rapidli
progress
sepsi
coagulopathi
patient
multipl
area
necrosi
separ
viabl
bowel
sever
option
avail
histor
surgeon
excis
diseas
segment
individu
creat
multipl
stoma
rather
perform
massiv
resect
convers
singl
high
stoma
proxim
jejunum
may
creat
distal
bowel
splice
togeth
therebi
avoid
multipl
stoma
proxim
jejunostomi
caus
signific
fluid
electrolyt
loss
peristom
skin
complic
although
aggress
skin
care
measur
replac
stoma
loss
avoid
potenti
complic
anastomot
strictur
uncommon
address
time
jejunostomi
closur
resect
plu
anastomosi
also
gain
increas
accept
valid
treatment
option
sever
nec
multifoc
diseas
studi
involv
infant
multifoc
nec
fasoli
et
al
report
higher
surviv
rate
resect
primari
anastomosi
versu
enterostomi
moor
describ
controversi
approach
term
patch
drain
wait
procedur
principl
potenti
bowel
lengthpreserv
method
transvers
singlelay
sutur
approxim
perfor
patch
insert
two
penros
drain
exit
lower
quadrant
drain
commit
longterm
parenter
nutrit
wait
penros
drain
captur
fecal
fistula
function
de
facto
enterostomi
periton
caviti
rapidli
obliter
adhes
procedur
address
issu
ongo
sepsi
necrot
bowel
resect
gener
periton
caviti
difficult
drain
thinwal
perfor
bowel
often
handl
sutur
vaughan
et
al
describ
promis
novel
techniqu
aim
avoid
multipl
enterostomi
circumv
complic
high
jejunostomi
preserv
bowel
length
author
perform
clip
drop
back
techniqu
three
patient
nec
procedur
obvious
necrot
bowel
remov
cut
end
close
titanium
clip
stapl
reexplor
perform
hour
later
clip
remov
segment
reanastomos
without
stoma
one
three
patient
reresect
requir
secondlook
oper
bowel
end
clip
success
primari
anastomosi
perform
third
oper
followup
small
seri
month
year
anastomot
complic
delay
reoper
paninvolv
develop
patient
pose
enorm
treatment
problem
highli
controversi
manag
issu
overrid
consider
spare
much
intestin
possibl
treatment
option
includ
resect
necrot
bowel
placement
proxim
multipl
stoma
proxim
divers
without
bowel
resect
plan
secondlook
procedur
decis
forego
treatment
support
studi
demonstr
mortal
rate
patient
paninvolv
almost
survivor
left
shortbowel
syndrom
mortal
rate
nearli
infant
weigh
less
g
divert
intestin
stream
high
proxim
jejunostomi
without
bowel
resect
may
facilit
heal
injur
bowel
distal
intestin
decompress
reduct
metabol
demand
decreas
number
bacteria
possibl
byproduct
techniqu
initi
report
martin
neblett
involv
perform
high
jejunostomi
without
resect
plan
secondlook
oper
week
seri
patient
paninvolv
sugarman
kieli
report
infant
surviv
undergo
second
procedur
resect
necrot
segment
plu
anastomosi
perform
success
longterm
surviv
rate
neither
ideal
weight
age
univers
agre
upon
time
intestin
continu
restor
princip
determin
time
sinc
surgeri
weight
gain
stoma
output
gener
enterostomi
may
safe
close
anytim
week
sinc
last
oper
risk
period
strictur
attempt
closur
less
week
surgeri
may
met
periton
caviti
obliter
vascular
adhes
resolv
inflamm
enterostomi
closur
patenc
distal
end
bowel
confirm
either
retrograd
antegrad
contrast
studi
studi
musemech
et
al
examin
complic
rate
stoma
close
less
month
surgeri
month
surgeri
month
surgeri
differ
found
also
note
differ
complic
patient
underw
closur
bodi
weight
less
kg
kg
greater
kg
although
enterostomi
neonat
may
lifesav
also
major
caus
morbid
recent
studi
enterostomi
newborn
associ
complic
rate
rang
complic
includ
wound
infect
wound
dehisc
stoma
stenosi
requir
revis
incision
hernia
parastom
hernia
prolaps
intussuscept
small
bowel
obstruct
past
decad
surviv
infant
nec
progress
improv
tabl
improv
attribut
earlier
diagnosi
effect
support
treatment
prematur
infant
effect
support
treatment
includ
improv
ventilatori
strategi
surfact
therapi
total
parenter
nutrit
improv
understand
pathophysiolog
manag
critic
ill
newborn
advanc
pediatr
anesthesia
increas
surviv
notic
infant
weigh
less
g
less
week
gestat
age
recent
review
prematur
infant
born
week
gestat
overal
surviv
rate
rang
week
gestat
week
gestat
mortal
still
significantli
higher
vlbw
infant
larger
patient
highlight
studi
examin
outcom
vlbw
infant
comparison
standard
prematur
infant
g
paninvolv
nec
snyder
et
al
found
infant
weigh
less
g
like
requir
surgeri
versu
eventu
paninvolv
versu
infant
greater
g
paninvolv
associ
mortal
group
retrospect
studi
infant
weigh
less
g
perfor
nec
erhlich
et
al
demonstr
infant
surviv
independ
type
surgic
treatment
pd
versu
laparotomi
instead
invers
relat
number
comorbid
condit
associ
patient
believ
differ
mortal
rate
seri
attribut
differ
effect
treatment
program
use
differ
group
patient
diseas
vari
predominantli
local
diseas
extens
necrosi
patient
popul
differ
variou
seri
mortal
rate
vari
consider
depend
birth
weight
coexist
diseas
virul
diseas
process
whether
patient
inborn
local
versu
transfer
precari
state
patient
risk
nec
emphas
fact
one
seri
compar
patient
nec
match
control
mortal
rate
control
first
clinic
radiolog
descript
intestin
strictur
recoveri
acut
nec
report
rabinowitz
et
al
report
overal
incid
vari
strictur
format
frequent
nonop
treatment
incid
strictur
nec
increas
mortal
rate
diseas
decreas
strictur
result
fibrot
heal
area
sever
ischem
injuri
regardless
whether
strictur
follow
oper
nonop
therapi
common
site
involv
colon
next
common
site
termin
ileum
sixti
percent
colon
strictur
involv
left
colon
common
colon
site
splenic
flexur
patient
singl
strictur
multipl
strictur
occur
intestin
strictur
suspect
nonop
manag
nec
infant
failur
thrive
rectal
bleed
bowel
obstruct
sign
symptom
occur
patient
strictur
evalu
contrast
enema
studi
demonstr
strictur
symptomat
patient
elect
resect
anastomosi
usual
indic
cholestat
liver
diseas
result
number
factor
primarili
prolong
administr
total
parenter
nutrit
character
direct
hyperbilirubinemia
hepatomegali
elev
aminotransferas
level
although
condit
multifactori
import
contribut
factor
probabl
prolong
fast
shown
effect
treatment
establish
earli
smallvolum
enter
feed
concomit
administr
total
parenter
nutrit
aid
bowel
adapt
confer
trophic
effect
intestin
mucosa
stimul
bile
flow
nec
recur
oper
nonop
manag
incid
consist
associ
note
recurr
nec
type
time
enter
feed
anatom
site
method
initi
manag
patient
success
treat
nonop
recurr
stringer
et
al
late
complic
may
occur
mani
year
resect
nec
develop
anastomot
ulcer
sondheim
et
al
report
six
children
underw
ileocolon
resect
anastomosi
neonat
period
lower
gi
bleed
develop
year
age
anastomot
ulcer
diagnos
colonoscopi
treatment
entail
ulcer
resect
five
six
patient
recurr
margin
ulcer
develop
four
five
patient
underw
resect
histolog
examin
reveal
shallow
ulcer
penetr
musculari
caus
ulcer
unknown
length
hospit
infant
strongli
associ
development
progress
year
age
probabl
reflect
advers
effect
medic
social
factor
develop
brain
recommend
development
screen
perform
everi
month
first
year
everi
month
second
year
longterm
followup
data
suggest
normal
prematur
infant
survivor
sever
nec
remain
high
risk
neurolog
development
morbid
approxim
infant
surviv
nec
neurodevelopment
normal
histor
believ
advers
neurodevelopment
outcom
patient
treat
nec
due
underli
prematur
comorbid
condit
rather
nec
recent
evalu
surviv
infant
contest
assumpt
vohr
et
al
studi
neurodevelopment
neurosensori
function
outcom
extrem
lowbirthweight
g
survivor
month
correct
age
report
signific
deficit
neurolog
develop
bayley
ii
mental
development
index
less
psychomotor
develop
index
less
vision
impair
hear
impair
nec
specif
associ
risk
factor
abnorm
neurolog
examin
low
bayley
psychomotor
develop
index
studi
assess
effect
nec
neurodevelop
sonntag
et
al
compar
vlbw
infant
nec
match
infant
without
nec
month
correct
age
despit
normal
somat
growth
infant
nec
complic
shortbowel
syndrom
author
demonstr
signific
neurodevelopment
delay
month
age
fiftyf
percent
infant
nec
note
sever
retard
versu
infant
without
nec
attempt
reduc
incid
prevent
nec
must
consid
probabl
pathogenesi
diseas
put
perinat
risk
factor
investig
prevent
measur
nec
includ
limit
nosocomi
spread
microorgan
augment
host
defens
decreas
bacteri
colon
overgrowth
gi
tract
provid
factor
enhanc
intestin
matur
attenu
inflammatori
cascad
may
use
infect
control
measur
breastfeed
cautiou
feed
sick
prematur
babi
immunoglobulin
supplement
feed
corticosteroid
therapi
administr
growth
factor
use
inflammatori
mediat
antagonist
prevent
strategi
studi
adopt
infect
control
measur
nurseri
may
limit
incid
restrict
spread
infect
therebi
potenti
elimin
epidem
wave
nec
tradit
prophylaxi
nosocomi
epidem
includ
strict
hand
wash
germicid
agent
longsleev
gown
glove
separ
diaper
laundri
bag
patient
cohort
isol
confirm
case
separ
room
nurs
confirm
case
without
crosscov
demonstr
initi
infect
control
measur
stop
epidem
nec
cluster
occurr
ident
microorgan
isol
afflict
neonat
caretak
protect
immunoglobulin
princip
iga
defici
prematur
gut
absenc
breastfeed
trace
amount
secretori
iga
gutassoci
igg
igm
secretori
iga
act
antisept
paint
bind
bacteria
prevent
attach
intestin
mucosa
eibl
et
al
demonstr
enter
administr
iggiga
prepar
decreas
incid
nec
random
trial
involv
feed
highrisk
infant
weigh
g
human
prepar
igg
iga
formula
wherea
control
receiv
formula
alon
neither
group
receiv
breast
milk
case
nec
develop
immunoglobulin
group
case
develop
control
recent
studi
rabbit
dickinson
et
al
demonstr
iga
supplement
feed
prevent
bacteri
transloc
enhanc
gut
mucos
barrier
function
effect
seen
igg
lactoferrin
random
doubleblind
control
trial
enter
igg
supplement
infant
fail
reduc
incid
nec
glucocorticoid
shown
acceler
mucos
cell
matur
improv
gut
barrier
function
action
mediat
glycosyl
intestin
surfac
impair
bacteri
attach
glucocorticoid
also
shown
downregul
inflammatori
respons
stimul
enzymat
degrad
paf
observ
made
experiment
clinic
bauer
et
al
retrospect
note
signific
reduct
incid
nec
babi
born
mother
receiv
antenat
glucocorticoid
fetal
pulmonari
matur
compar
control
versu
larg
multicent
placebocontrol
trial
well
control
mani
potenti
confound
variabl
halac
et
al
conduct
random
control
trial
prenat
glucocorticoid
administr
mother
preterm
labor
control
mother
receiv
placebo
infant
receiv
immedi
postnat
cours
highdos
dexamethason
day
rate
nec
within
group
significantli
decreas
prenat
postnat
steroid
treatment
although
postnat
therapi
decreas
incid
effect
prenat
therapi
improv
clinic
outcom
nec
howev
mani
potenti
confound
factor
assess
studi
confirmatori
prospect
data
assess
potenti
postnat
toxic
need
breast
milk
decreas
risk
number
neonat
infect
includ
lower
respiratori
tract
ill
otiti
media
bacteremia
mening
nec
human
milk
provid
array
humor
cellular
antiinfecti
factor
growth
factor
probiot
well
essenti
vitamin
nutrient
milk
factor
includ
iga
macrophag
lymphocyt
compon
complement
system
lactoferrin
lysozym
transferrin
interferon
egf
alpha
fetoprotein
erythropoietin
probiot
bifidobacterium
infanti
lactobacillu
acidophilu
paf
acetylhydrolas
sever
inflammatori
mediat
strong
evid
exist
protect
role
secretori
iga
main
immun
compon
enteromammari
axi
breast
milk
also
inhibit
growth
e
coli
provid
acid
environ
promot
competit
growth
lactobacillu
bifidu
bind
iron
element
essenti
growth
e
coli
invas
infecti
agent
seem
prime
factor
pathogenesi
nec
breast
milk
appear
ideal
suit
protect
infant
diseas
administr
breast
milk
prevent
experiment
nec
formulaf
babi
four
six
time
incid
nec
breastf
infant
littl
disagr
nec
common
fed
infant
bacteri
overgrowth
facilit
substrat
provid
formula
although
potenti
benefit
care
regul
feed
prevent
nec
wide
accept
random
trial
fail
demonstr
differ
incid
nec
relat
fast
versu
slow
earli
versu
delay
continu
versu
intermitt
bolu
feed
lowbirthweight
infant
infant
ill
prenat
problem
fed
day
nutrit
provid
parenter
symptom
suggest
nec
develop
feed
cautious
begun
type
concentr
rate
increas
univers
accept
although
clinician
begin
hypocalor
formula
slow
rate
feed
withheld
infant
evalu
gastric
residu
increas
clinic
find
potenti
associ
nec
develop
probiot
bacteria
defin
live
microbi
supplement
colon
intestin
provid
benefit
host
use
anaerob
bacteri
supplement
treatment
prevent
gi
diseas
well
describ
increas
interest
use
probiot
prevent
nec
bifidobacteria
gramposit
anaerob
bacteria
predominantli
colon
gut
healthi
breastfeed
neonat
much
less
preval
intestin
tract
prematur
infant
highest
risk
nec
preliminari
investig
neonat
rat
model
nec
use
probiot
supplement
demonstr
signific
reduct
incid
nec
futur
human
clinic
trial
need
nonabsorb
broadspectrum
antibiot
inhibit
bacteri
growth
administ
effort
prevent
nec
use
enter
aminoglycosid
eg
kanamycin
gentamicin
propos
mean
decreas
incid
perfor
nonop
treatment
howev
random
control
studi
found
differ
clinic
cours
complic
mortal
rate
infant
receiv
antibiot
addit
oral
aminoglycosid
may
absorb
across
damag
gut
lead
increas
serum
level
therebi
potenti
contribut
drug
toxic
resist
strain
bacteria
emerg
treatment
enter
kanamycin
omnipres
risk
promot
growth
fungal
speci
recent
random
placebocontrol
studi
oral
vancomycin
prevent
nec
preterm
infant
siu
et
al
report
reduct
incid
nec
vancomycin
group
comparison
control
avail
studi
support
routin
administr
enter
antibiot
highrisk
prematur
infant
mani
poor
intestin
motil
effect
prove
resist
organ
may
develop
administ
specif
antibiot
infant
may
indic
nurseri
outbreak
nec
associ
specif
organ
carrion
egan
conduct
small
prospect
doubleblind
studi
feed
given
prematur
infant
acidifi
hcl
ph
acidif
feed
significantli
decreas
rate
gastric
bacteri
colon
infant
gastric
ph
less
also
found
significantli
lower
incid
nec
infant
given
acidifi
feed
control
effect
paf
mediat
receptor
mani
compound
function
receptor
antagonist
enzym
degrad
protein
describ
anim
experi
use
paf
antagonist
web
web
sri
pafdegrad
enzym
paf
acetylhydrolas
demonstr
capac
prevent
bowel
injuri
produc
administr
endotoxin
hypoxia
rat
paf
acetylhydrolas
also
known
present
breast
milk
despit
promis
result
anim
model
human
trial
use
paf
antagonist
degrad
enzym
treatment
nec
report
